Imbio announces new collaboration with GE Healthcare

Imbio, a Minneapolis, Minn.-based diagnostic imaging software company, announced this week that its Lung Density Analysis (LDA) will be one of the first software applications available on the GE Health Cloud.

The news comes as a result of a new collaboration between Imbio and GE Healthcare. LDA, a product designed for lung CT, will be integrated into GE Health Cloud’s clinical workflow, allowing customers subscribing to LDA to have their CT lung images uploaded automatically for processing.

“At Imbio, we are working to break down the barriers to broader use of clinically valuable quantitative imaging,” Cynthia Maier, Imbio CEO, said in a prepared statement. “Partnering with GE to bring Lung Density Analysis to the GE Health Cloud is directly aligned with our focus on fully-automated applications to improve productivity, while making richer, personalized patient analysis accessible to all physicians to aid their diagnosis and care planning.”

According to Imbio, integration of LDA is just the first step of the collaboration between these two companies.

“This partnership with Imbio confirms our commitment to providing healthcare professionals with enhanced quantifiable clinical insights,” Evren Eryurek, GE Healthcare software chief technology officer, said in the same statement. “By incorporating Imbio's personalized lung analysis into GE Healthcare's cloud­-enabled workflow solutions, we are enriching the data that we can provide through the GE Health Cloud.”